-+ 0.00%
-+ 0.00%
-+ 0.00%

Deutsche Bank Upgrades Elevance Health to Buy, Raises Price Target to $498

Benzinga·05/20/2026 12:38:09
Listen to the news
Deutsche Bank analyst George Hill upgrades Elevance Health (NYSE:ELV) from Hold to Buy and raises the price target from $363 to $498.